Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan-Feb;63(1):4-9.
doi: 10.1016/j.pcad.2019.11.012. Epub 2019 Nov 20.

Impact of therapeutic lifestyle changes in resistant hypertension

Cemal Ozemek  1 , Stephanie Tiwari  2 , Ahmad Sabbahi  3 , Salvatore Carbone  4 , Carl J Lavie  5
Affiliations
Review

Impact of therapeutic lifestyle changes in resistant hypertension

Cemal Ozemek et al. Prog Cardiovasc Dis. 2020 Jan-Feb.

Abstract

Hypertensive individuals are at an increased risk of developing heart disease and stroke. Adopting healthy lifestyles, such as being active on ≥4 days per week, weight-loss in the presence of obesity, consuming a diet rich in fruits and vegetables, and sodium below the recommended threshold, avoiding high alcohol consumption and refraining from smoking have been effective lifestyle therapies to prevent or control stage 1 hypertension (HTN). Among the 1 in 3 Americans who have HTN (systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 80 mmHg), 16% are diagnosed with resistant HTN (RHT). Although there are comparatively fewer studies examining the blood pressure lowering effects of therapeutic lifestyle interventions in patients with resistant HTN, the available literature appears promising. This paper reviews key studies that quantify the blood pressure lowering effects of certain therapeutic lifestyles in patients with RHT and highlights areas needing more attention.

Keywords: DASH diet; Lifestyle change; Physical activity; Resistant hypertension.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: None

Comment in

  • Cardiovascular Statistics 2021.
    Lavie CJ. Lavie CJ. Prog Cardiovasc Dis. 2021 Jul-Aug;67:114-115. doi: 10.1016/j.pcad.2021.07.012. Prog Cardiovasc Dis. 2021. PMID: 34412825 No abstract available.

References

    1. Forouzanfar MH, Liu P, Roth GA, et al. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990–2015. Jama. 2017;317:165–182. - PubMed
    1. Benjamin EJ, Virani SS, Callaway CW, et al. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation. 2018;137:e67–e492. - PubMed
    1. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018;138:e484–e594. - PubMed
    1. Muntner P, Carey RM, Gidding S, et al. Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline. Circulation. 2018;137:109–118. - PMC - PubMed
    1. Bundy JD, Mills KT, Chen J, Li C, Greenland P, He J. Estimating the Association of the 2017 and 2014 Hypertension Guidelines With Cardiovascular Events and Deaths in US Adults: An Analysis of National Data. JAMA Cardiol. 2018;3:572–581. - PMC - PubMed

Publication types

Substances